| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | RQ-002303078 |
|---|
| Description | RQ-00203078 is a potent, selective TRPM8 antagonist (IC50 values are 5.3 and 8.3 nM for rat and human channels respectively). Displays >350-fold selectivity for TRPM8 over TRPV4, TRPV1 and TRPA1. RQ-00203078 blocks TRPM8 activity and reduces the invasion potential of oral squamous carcinoma cell lines. RQ-00203078 (RQ) profoundly reduced such agonist-induced cation currents. MW: 554.85. Purity ≥98% by HPLC |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 4-[[[3-Chloro-5-(trifluoromethyl)-2-pyridinyl][[4-(trifluoromethoxy)phenyl]methyl]amino]sulfonyl]benzoic ac |
|---|
| Gene, Accession, CAS # | CAS: 1254205-52-1 |
|---|
| Catalog # | 9636-10 |
|---|
| Price | |
|---|
| Order / More Info | RQ-002303078 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|